High Dose Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes

Trial Profile

High Dose Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2017 Planned End Date changed from 1 Dec 2016 to 1 May 2018.
    • 30 Oct 2016 Primary endpoint (Hospitalization rate) has been met, according to the results presented at the IDWeek 2016
    • 30 Oct 2016 Results presented at the IDWeek 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top